Franchise Capital’s Enfusion, Inc. ENFN Stock Holding History

Franchise Capital’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-62,709	Closed	-$658K	–	26
2023 Q1	$658K	Sell	62,709 -125,596	-67%	-$1.38M	0.17%	20
2022 Q4	$1.82M	Buy	+188,305	New	+$2.12M	0.56%	14
2022 Q3	–	Sell	-406,915	Closed	-$4.16M	–	28
2022 Q2	$4.16M	Sell	406,915 -231,912	-36%	-$2.56M	1.39%	17
2022 Q1	$8.13M	Buy	638,827 +49,954	+8%	+$763K	2.23%	14
2021 Q4	$12.3M	Buy	+588,873	New	+$11.9M	2.09%	14

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Franchise Capital's ENFN Position: Q2 2023 in Review

Franchise Capital sold out of Enfusion, Inc. (ENFN) in Q2 2023, closing a stake of 62,709 shares — an estimated $658K sold.

Franchise Capital first reported a position in ENFN in Q4 2021 and held it in 5 quarters. The position peaked at $12.3M in Q4 2021. 83 funds tracked by Wall St. Rank hold ENFN as of Q2 2023.

Franchise Capital reported no remaining Enfusion, Inc. position as of Q2 2023 after selling out during the quarter.
Franchise Capital sold 62,709 Enfusion, Inc. shares in Q2 2023, an estimated $658K.
Franchise Capital first reported a position in Enfusion, Inc. in Q4 2021 and held it in 5 quarters.
Franchise Capital's Enfusion, Inc. position peaked at $12.3M in Q4 2021.
83 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2023.

Based on Franchise Capital's 13F filing for Q2 2023, filed 16 Aug 2023.